This finding could lead to early diagnosis and treatment, the researchers said. In 2008, there were 37,340 new cases of thyroid cancer and 1,590 deaths, according to the U.S. National Cancer ...

New thyroid cancer gene discovered. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2015 / 10 / 151029134120.htm. Cleveland Clinic. "New thyroid cancer gene discovered." ...

Researchers have long focused on the STING (Stimulator of Interferon Genes) pathway as a way to harness the immune system's ...

Gene therapy for thyroid cancer represents a new technology that, more than any currently available therapy, takes direct advantage of our new understanding of thyroid carcinogenesis at the ...

To analyze the genetics behind thyroid cancer, the researchers will test genetic associations directly using a GWAS meta-analysis with 12,091 thyroid cancer cases, 56,949, patients with benign ...

STING (stimulator of interferon genes) is a key mediator of innate immunity and the STING pathway has been shown to be involved in the induction of an anti-tumor immune response. We recently spoke to ...

The gene changes that lead to thyroid cancer are usually acquired rather than inherited. This means the changes occur due to something in a person’s environment, such as radiation exposure ...

Thyroid cancer is a type of cancer that particularly affects females. While its exact causes are largely unknown, multiple risk factors can contribute to its development, including genetic factors ...

Researchers at Memorial Sloan Kettering Cancer Center have discovered that the STING cellular signaling pathway plays a key role in preventing dormant cancer cells from progressing into aggressive ...

RET fusions are found in about 10 percent of thyroid tumors that originate in follicular cells. This includes anaplastic thyroid cancer, the most aggressive and difficult-to-treat form of the disease.

On February 5, 2024, a new research paper was published in Oncotarget, entitled, “Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and ...